Quick Answer
PAVmed Inc. reported Operating Income Loss of -$21.81 million for the year ending 2025.
- PAVmed Inc. showed an increase of +51.0% in Operating Income Loss from 2024 to 2025.
- This data is from PAVmed Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2016 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 10 years of available data (2016 to 2025), PAVmed Inc.'s Operating Income Loss has declined by 285.9%.
- Historical annual values: Fiscal year 2025: -$21.81 million | Fiscal year 2024: -$44.49 million | Fiscal year 2023: -$68.80 million | Fiscal year 2022: -$91.09 million | Fiscal year 2021: -$54.39 million | Fiscal year 2020: -$23.35 million | Fiscal year 2019: -$14.30 million | Fiscal year 2018: -$10.56 million | Fiscal year 2017: -$8.03 million | Fiscal year 2016: -$5.65 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: